<?xml version="1.0" encoding="UTF-8"?>
<p id="Par6">Hematopoietic stem cell transplantation (HSCT) allows the treatment of numerous diseases in both children and adults, such as hematologic malignancies, non-malignant hemopathies, and severe immunodeficiencies [
 <xref ref-type="bibr" rid="CR1">1</xref>, 
 <xref ref-type="bibr" rid="CR2">2</xref>]. HSCT became possible in the 1960s, after identification and typing of the human leukocyte antigen (HLA) [
 <xref ref-type="bibr" rid="CR3">3</xref>].
</p>
